Is RSV Making Headlines? Here’s What You Should KnowRespiratory infections like RSV (respiratory syncytial virus) can strike at any time, but recent reports have brought increased attention to this virus...reactionscomments
COVID-19 and Flu: Similarities, Differences, and How to Protect YourselfAs the coronavirus and flu season collide, this upcoming fall and winter will be like none the world has ever seen. Here...reactionscomments
Viona Pharmaceuticals Recalls Metformin Extended-Release TabletsThe U.S. Food and Drug Administration (FDA) is notifying doctors and people who take metformin that Viona Pharmaceuticals has voluntarily recalled 33...reactionscomments
New Lower-Cost Insulin Analog: ReliOn™ NovoLog®Walmart announced its first-ever branded insulin analog, ReliOn™ NovoLog®, on Thursday, June 29. ReliOn NovoLog is a fast-acting injection that is used...reactionscomments
Recall of Metformin Hydrochloride Extended-Release TabletsOn October 2, 2020, drug company Marksans Pharma Limited, India voluntarily expanded an earlier recall of metformin extended-release (ER) tablets (500 mg...reactionscomments
Freestyle Libre - Flash Glucose MonitorThe time is finally here, that we can know what our blood glucose (bg) level is WITHOUTpricking our finger!! On September 27...reactionscomments
News from Dexcom!I recently learned exciting news that I felt was important to share with the type2diabetes.com community. As of January 12, 2017, the...reactionscomments
New (More Moderate) Guidelines for HbA1c LevelsThe American College of Physicians (ACP) has issued new guidelines regarding the target blood sugar control levels for people with type 2...reactionscomments
FDA Approves First Generic Drug Used to Treat Severe HypoglycemiaThe U.S. Food and Drug Administration (FDA) has approved the first generic glucagon for injection to treat severe hypoglycemia (very low blood...reactionscomments
COVID-19 Updates, June 15: Solidarity Hydroxychloroquine Trials and COVID Vaccine DevelopmentMany of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be...reactionscomments
COVID-19: Tips To Reduce Your RiskWith all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is...reactionscomments
In Response to COVID-19, Lilly Insulin Value Program Allows $35 Co-PayThe current COVID-19 pandemic has led many to experience financial and employment strain. Some pharmaceutical companies are taking action to make sure...reactionscomments
COVID-19 Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about...reactionscomments
Nostrum Laboratories Voluntarily Recalls an Additional Lot of Extended Release MetforminThe U.S. Food and Drug Administration (FDA) is notifying healthcare professionals and people who take metformin that Nostrum Laboratories has voluntarily recalled...reactionscomments
COVID-19 Updates, July 16: Updates on People at Risk, Testing, Reopening, and a VaccineEven after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are...reactionscomments
FDA Approves Drug to Reduce Risk of Serious Kidney and Heart Complications in Adults With Chronic Kidney DiseaseThe US Food and Drug Administration (FDA) has approved Kerendia™(finerenone) for adults with chronic kidney disease associated with type 2 diabetes. It...reactionscomments
FDA Approves Zegalogue® (dasiglucagon) Injection to Treat Severe Hypoglycemia in People With DiabetesThe U.S. Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon) injection to treat severe hypoglycemia (low blood sugar) in people with...reactionscomments
Research Opportunity: Health LiteracyThere is a new opportunity to participate in a research study about health literacy. Sherene, who is conducting the study, explains more...reactionscomments
